Pharmaceutical Market outlook to 2018

Chapter 1  Challenges and resistors to
growth 18
Summary  18
Introduction 19
New challenges faced by the industry in 2004 19
Full clinical trial data disclosure 19
Accusations of industry and FDA collusion 20
Major product recalls 20
Plummeting stock values 21
Continuing challenges 22
Weakening product pipelines 23
Soaring costs of R&D 25
Increasing generic competition and parallel trade 25
Increased cost containment 29
Opportunities in the pharmaceutical marketplace 31

Chapter 5  Future growth and alliance
strategies 90
Summary  90
Introduction 91
Alliances between industry sectors 92
The issue of scale 93
Scale in R&D operations 94
Scale in sales and marketing operations 95
Strategies beyond mega-mergers 96
Re-organization of internal R&D 97
Exploiting external R&D resources 98
Alliance deals 99
Collaborative alliances 100
Technology licensing 100
Buyer-supplier relationships 101
Evaluations 101
Mergers and acquisitions (M&A) 101
Forecast to 2015 102